Skip to main content

Table 2 Outcome of five patients with persistent hypercortisolaemia after initial ETSS

From: Outcomes of endoscopic transsphenoidal surgery for Cushing's disease

 

Pre-operative MRI

D3 0800h serum cortisol (nmol/L)

1st ETSS

Subsequent management

1

Microadenoma

555

Second ETSS – in remission, D3 cortisol 41 nmol/L.

2

Microadenoma

306

Second ETSS – persistent mild hypercortisolemia, D3 cortisol 80 nmol/L.

3

Nil visible

386

Second ETSS – persistent disease, D3 cortisol 379 nmol/L.

Medical therapy with cabergoline and stereotactic radiosurgery.

4

Nil visible

779

Bilateral adrenalectomy

5

Macroadenoma with cavernous sinus invasion

497

Medical therapy with metyrapone.

Fractionated pituitary radiotherapy